Whitlock; Gavin Alistair
Patent Applications and Registrations
Patent applications and USPTO patent grants for Whitlock; Gavin Alistair.The latest application filed is for "novel oxaborole analogs and uses thereof".
- Whitlock; Gavin Alistair - Canterbury GB
- Whitlock; Gavin Alistair - Deal GB
- Whitlock; Gavin Alistair - Sandwich Kent GB
- Whitlock; Gavin Alistair - Sandwich GB
- Whitlock; Gavin Alistair - Samdwich GB
- Whitlock; Gavin Alistair - US
- Whitlock; Gavin Alistair - County of Kent GB
| Patent | Date |
|---|---|
| Novel Oxaborole Analogs And Uses Thereof App 20210253605 - Jacobs; Robert Toms ; et al. | 2021-08-19 |
| Oxaborole analogs and uses thereof Grant 10,961,261 - Jacobs , et al. March 30, 2 | 2021-03-30 |
| Novel Compounds App 20200369658 - Jones; Alison ; et al. | 2020-11-26 |
| Compounds Grant 10,774,078 - Jones , et al. Sept | 2020-09-15 |
| 2-cyanoisoindoline derivatives for treating cancer Grant 10,683,269 - Gibson , et al. | 2020-06-16 |
| Compounds Grant 10,640,498 - Gibson , et al. | 2020-05-05 |
| Novel Oxaborole Analogs And Uses Thereof App 20200024289 - Jacobs; Robert Toms ; et al. | 2020-01-23 |
| Novel Compounds App 20190330202 - Jones; Alison ; et al. | 2019-10-31 |
| Compounds Grant 10,392,380 - Jones , et al. A | 2019-08-27 |
| Novel Compounds App 20190055232 - GIBSON; Karl Richard ; et al. | 2019-02-21 |
| 2-cyanoisoindoline Derivatives For Treating Cancer App 20190010122 - GIBSON; Karl Richard ; et al. | 2019-01-10 |
| Pyrazolopyridines and pyrazolopyrimidines Grant 10,022,376 - Coe , et al. July 17, 2 | 2018-07-17 |
| Novel Compounds App 20180162852 - Jones; Alison ; et al. | 2018-06-14 |
| Compounds Grant 9,926,307 - Jones , et al. March 27, 2 | 2018-03-27 |
| Novel Compounds App 20170247365 - Jones; Alison ; et al. | 2017-08-31 |
| Pyrazolopyridines And Pyrazolopyrimidines App 20170071946 - Coe; Jotham Wadsworth ; et al. | 2017-03-16 |
| Pyrazolopyridines and pyrazolopyrimidines Grant 9,518,052 - Coe , et al. December 13, 2 | 2016-12-13 |
| Pyrazolopyridines And Pyrazolopyrimidines App 20150329542 - Coe; Jotham Wadsworth ; et al. | 2015-11-19 |
| Indazoles Grant 8,895,544 - Coe , et al. November 25, 2 | 2014-11-25 |
| Indazoles App 20140024634 - Coe; Jotham Wadsworth ; et al. | 2014-01-23 |
| Indazoles Grant 8,575,336 - Coe , et al. November 5, 2 | 2013-11-05 |
| Indazoles App 20130029968 - Coe; Jotham Wadsworth ; et al. | 2013-01-31 |
| Morpholine Compounds, Pharmaceutically Acceptable Salts Thereof, Pharmaceutical Compositions, and Methods Of Use Thereof App 20100137316 - Fish; Paul Vincent ; et al. | 2010-06-03 |
| Novel Compounds App 20080306123 - Fish; Paul Vincent ; et al. | 2008-12-11 |
| Novel Compounds App 20080161309 - Fish; Paul Vincent ; et al. | 2008-07-03 |
| Compounds Grant 7,378,436 - Fish , et al. May 27, 2 | 2008-05-27 |
| Piperazine derivatives which exhibit activity as serotonin and noradrenaline re-uptake inhibitors App 20070105870 - Bish; Gerwyn ; et al. | 2007-05-10 |
| 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen C-proteinase inhibitors Grant 7,214,694 - Datta , et al. May 8, 2 | 2007-05-08 |
| Amides useful as monoamine re-uptake inhibitors Grant 7,122,683 - Fish , et al. October 17, 2 | 2006-10-17 |
| Novel compounds App 20060111429 - Fish; Paul Vincent ; et al. | 2006-05-25 |
| Novel compounds App 20050250775 - Fish, Paul Vincent ; et al. | 2005-11-10 |
| Novel compounds App 20050137229 - Fish, Paul Vincent ; et al. | 2005-06-23 |
| 3-heterocyclypropanohydroxamic acid PCP inhibitors Grant 6,831,088 - Fish , et al. December 14, 2 | 2004-12-14 |
| 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen C-proteinase inhibitors App 20040142986 - Datta, Usa ; et al. | 2004-07-22 |
| 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen C-proteinase inhibitors Grant 6,716,861 - Datta , et al. April 6, 2 | 2004-04-06 |
| 3-Heterocyclylpropanohydroxamic acid PCP inhibitors App 20040058917 - Fish, Paul Vincent ; et al. | 2004-03-25 |
| 3-heterocyclylpropanohydroxamic acid PCP inhibitors Grant 6,645,993 - Fish , et al. November 11, 2 | 2003-11-11 |
| Metalloprotease inhibitors Grant 6,511,993 - Dack , et al. January 28, 2 | 2003-01-28 |
| Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitors Grant 6,495,568 - Dack , et al. December 17, 2 | 2002-12-17 |
| Substituted alpha-aminosulphonyl-acetohydroxamic acids as therapeutic agents Grant 6,090,852 - Dack , et al. July 18, 2 | 2000-07-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 